Trulicity for Seniors: Evidence, Eligibility, Coverage

Trulicity has no separate rule for adults 65 and older. It is approved for type 2 diabetes and heart risk. In REWIND: 12% had a heart attack or stroke, or died from heart disease, vs 13.4% on placebo.

Active ingredient: dulaglutide
How it is taken: weekly injection
Approved for: Type 2 diabetes and heart risk
Best result (REWIND): 12% had a heart attack or stroke, or died from heart disease

Trulicity in brief

How long it remains in your body

Its half-life is about 5 days. After 5 d, half is gone, and after five half-lives (25 d), about 3% remains.

Source: FDA label on DailyMed.

Who qualifies?

Who qualifies to take Trulicity
Source	Who qualifies
FDA label	It lowers blood sugar for adults and children 10 and older with type 2 diabetes, when used alongside diet and exercise.
FDA label	Adults with type 2 diabetes who have heart disease, or who have multiple heart risk factors, see a lower risk of heart-related death, heart attack, or stroke with this medicine.

Source: FDA label on DailyMed.

Senior trial results

Trulicity studies in older adults
Trial	Medicine	Who took part	Length	People	Main result	Comparison
REWIND	Trulicity	Adults 50 and older with type 2 diabetes and either heart disease or risk factors	5.4 years (follow-up)	9,901	12% had a heart attack or stroke, or died from heart disease	13.4% on placebo

Trial sources: REWIND (PubMed).

What is different for seniors?

Trulicity: label points for older adults
What changes	What the label says
Hypoglycemia When Used With Insulin Secretagogues or Insulin	If you use it alongside insulin or a sulfonylurea, low blood sugar becomes more likely, so their doses may need to be reduced.
Acute Kidney Injury Due to Volume Depletion	Fluid loss from vomiting or diarrhea can lead to kidney injury. Drink fluids and report heavy fluid loss.
Taken with insulin or sulfonylureas	Combining it with insulin or with a sulfonylurea, for example glipizide or glimepiride, raises the chance of low blood sugar, and the doctor may reduce those doses.
Taken with warfarin and narrow-range drugs	A medicine where small level changes matter, such as warfarin, needs closer monitoring.

FDA labels provide this information: DailyMed source.

Label details: FDA label on DailyMed.

Coverage for seniors

For diabetes or cardiovascular disease, these prescribed medicines can fall under Medicare Part D coverage.

Part D plans may cover a GLP-1 for type 2 diabetes, moderate to severe sleep apnea or fatty liver disease.

A GLP-1 used only for weight loss will not receive coverage through Medicare Part D.

Weight-loss GLP-1s covered by Medicaid programs usually need prior authorization.

Sources: humana.com, medicare.gov, KFF.

Alternatives for seniors

GLP-1 medicines and older adults
Medicine	For older adults	How it is taken	Trial result
Trulicity	Approved uses apply	weekly injection	12% had a heart attack or stroke, or died from heart disease
Ozempic	Approved uses apply	weekly injection	Not listed
Wegovy	Approved uses apply	weekly injection or daily tablet	a heart attack, stroke, or death from heart disease occurred in 6.5%
Rybelsus	Approved uses apply	daily tablet	12% had a heart attack or stroke, or died from heart disease
Mounjaro	Approved uses apply	weekly injection	Not listed
Zepbound	Approved uses apply	weekly injection	Not listed
Foundayo	Approved uses apply	daily tablet	Not listed
Saxenda	Approved uses apply	daily injection	Not listed
Victoza	Approved uses apply	daily injection	Not listed
Byetta	Approved uses apply	twice-daily injection	Not listed